Preferred Label : Fragile X syndrome;
Symbol : FXS;
CISMeF acronym : FXS;
Type : Phenotype, molecular basis known;
Alternative titles and symbols : Martin-bell syndrome; Fragile X mental retardation syndrome; Mental retardation, X-linked, associated with marxq28; Marker X syndrome; X-linked mental retardation and macroorchidism;
Description : Fragile X mental retardation is characterized by moderate to severe mental retardation,
macroorchidism, and distinct facial features, including long face, large ears, and
prominent jaw. In most cases, the disorder is caused by the unstable expansion of
a CGG repeat in the FMR1 gene and abnormal methylation, which results in suppression
of FMR1 transcription and decreased protein levels in the brain (Devys et al., 1993).
- Reviews Fragile X syndrome accounts for about one-half of cases of X-linked mental
retardation and is the second most common cause of mental impairment after trisomy
21 (190685) (Rousseau et al., 1995). McCabe et al. (1999) summarized the proceedings
of a workshop on the fragile X syndrome held in December 1998. Jacquemont et al. (2007)
provided a review of fragile X syndrome, which they characterized as a neurodevelopmental
disorder, and FXTAS, which they characterized as a neurodegenerative disorder.;
Inheritance : X-linked dominant;
Molecular basis : Caused by mutation in the FMR1 gene (FMR1, 309550.0001);
Laboratory abnormalities : Folate-dependent fragile site at Xq28;
Prefixed ID : #300624;
Origin ID : 300624;
UMLS CUI : C0016667;
Automatic exact mappings (from CISMeF team)
DO Cross reference
Genes related to phenotype
HPO term(s)
ORDO concept(s)
Semantic type(s)
UMLS correspondences (same concept)